TABLE 2.

Tumour characteristics including site and staging (N = 95).

Site
iCCA	40 (42.1%)
pCCA	42 (44.2%)
dCCA	8 (8.4%)
Unknown	5 (5.3%)
Stage
pT1	24 (25.3%)
pT2	41 (43.1%)
pT3	11 (11.6%)
pT4	9 (9.5%)
Unknown	10 (1.1%)
Size
>2 cm	10/95
<2 cm	9/95
Unknown	76/95
Lymphatic invasion
Yes	9/95
No	16/95
Unknown	70/95
Vascular invasion
Yes	7/95
No	19/95
Unknown	69/95